$3.50
▲ +0.3% Today
as of Sep 4, 16:52 ET
Last 30 days
Recent Press Releases & News
NRx Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
NRX Pharmaceuticals Inc (NRXP) (Q2 2026) Earnings Call Highlights: Advancing Ketamine Pipeline ...
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET
Overview
52-week range
$1.62
$5.05
55% of range
Avg surprise (last 1)
+20.0%
Avg reaction (last 2)
+4.0%
100% positive
Latest IV / EM
375%
EM ±58.6% · $3 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-0.04 | $-0.05 | +20.0% | +88.2% | +2.2% | earnings |
| Mon Aug 18, 2025 | Jun/2025 | $-0.98 | — | — | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.34 | — | — | — | +5.7% | earnings |
| Sun Mar 31, 2024 | Mar 2024 | $-0.74 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.07 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.12 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-1.66 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $1M | — | $242,000 | $0 | $0 | — | $0 |
| Cost of revenue | $675,000 | $631,000 | — | $97,000 | $0 | $0 | — | $0 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-7M | $-5M | — | $-4M | $-4M | $-4M | — | $-3M |
| Net income | $-17M | $-1M | — | $-6M | $-18M | $-6M | — | $-2M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $27M | $7M | $8M | $7M | $3M | $6M | $1M | $2M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $29M | $7M | $9M | $12M | $5M | $7M | $3M | $4M |
| Total assets | $34M | $12M | $13M | $15M | $5M | $8M | $4M | $4M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $34M | $26M | $29M | $41M | $40M | $33M | $27M | $23M |
| Total equity | $-170,000 | $-14M | $-16M | $-26M | $-36M | $-25M | $-23M | $-19M |